4 recruiting, 3 completed, 1 unknown. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Recruiting 4, Completed 3, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Gastrointestinal Cancers: new trials by email Literature Review of Gastrointestinal Cancers trials Research Report on Gastrointestinal Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma BHB810 - Gastric Cancer, Gastric Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | BigHat Biosciences, Inc. | 164 | 2026-07-16 | 2026-10-20 |
| Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers Rina-S - Gastrointestinal Cancers | Phase 2 | Recruiting | Genmab | 160 | 2026-05-11 | 2026-11-03 |
| Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes 18F-FDG, [18F]F-PDL1-3 - Lung Cancer (NSCLC), Cervical Squamous Cell Cancer | Phase 2 | Recruiting | Peking University Cancer Hospital & Institute | 50 | 2026-02-01 | 2026-09-29 |
| Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer. CYTALUXâ„¢ (pafolacianine) injection preoperatively - Esophageal Cancer, Gastrointestinal Cancers | Phase 2 | Recruiting | John Waters | 50 | 2025-08-19 | 2026-06-05 |
| Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers [18F]FAPI-74 PET/CT - Gastrointestinal Cancers, Cholangiocarcinoma | Phase 2 | Completed | SOFIE | 112 | 2023-04-28 | 2026-10-01 |
| DPD Guided 5-FU Precision Treatment in Gastro-intestinal Cancer Patients 5-Fluoro-Uracil - Gastrointestinal Cancers | Phase 2 | Completed | Jan Gerard Maring | 80 | 2020-02-02 | 2025-01-17 |
| Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers Bevacizumab, Placebo - Malignant Ascites, Gastrointestinal Cancers | Phase 2 | Completed | AIO-Studien-gGmbH | 53 | 2010-02-01 | 2015-04-13 |
| Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy HIPEC: MMC 30mg @ T0, 10mg @ T45min, HIPEC: MMC + CDDP 30mg @ T0, 10mg @ T45min 50 mg/m2 @T0, HIPEC: CDDP 75 mg/m2 @T0 - Ovarian Cancer, Peritoneal Cancer | Phase 2 | Unknown | Bay Area Gynecology Oncology | 200 | 2006-09-01 | 2019-04-16 |
Gastrointestinal Neoplasms (8) · Stomach Neoplasms (2) · Adenocarcinoma (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Fallopian Tube Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1) · Mesothelioma (1) · Neoplasms (1)
Digestive System Diseases (8) · Digestive System Neoplasms (8) · Gastrointestinal Diseases (8) · Neoplasms by Site (8) · Neoplasms (7) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (3) · Carcinoma (2) · Colonic Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Stomach Diseases (2) · Adenocarcinoma (1)
Bevacizumab (1) · Fluorodeoxyglucose F18 (1) · Hyperthermic Intraperitoneal Chemotherapy (1) · Pafolacianine (1)
AIO-Studien-gGmbH (1) · Bay Area Gynecology Oncology (1) · BigHat Biosciences, Inc. (1) · Genmab (1) · Jan Gerard Maring (1) · John Waters (1) · Peking University Cancer Hospital & Institute (1) · SOFIE (1)
United States (5) · Germany (2) · Netherlands (2) · Australia (1) · Belgium (1) · China (1) · France (1) · Japan (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1)
Hua Zhu (1) · James Lilja, MD (1) · John Waters, M.D. (1) · Karin Jordan, Dr. med. (1)
2025 (1)